162 related articles for article (PubMed ID: 19676143)
1. Evaluation of biomarkers of exposure and potential harm in smokers, former smokers and never-smokers.
Lowe FJ; Gregg EO; McEwan M
Clin Chem Lab Med; 2009; 47(3):311-20. PubMed ID: 19676143
[TBL] [Abstract][Full Text] [Related]
2. Effects of reduced exposure to cigarette smoking on changes in biomarkers of potential harm in adult smokers: results of combined analysis of two clinical studies.
Sakaguchi C; Miura N; Ohara H; Nagata Y
Biomarkers; 2019 Jul; 24(5):457-468. PubMed ID: 31084221
[No Abstract] [Full Text] [Related]
3. Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers.
Warner JH; Liang Q; Sarkar M; Mendes PE; Roethig HJ
BMC Med Res Methodol; 2010 Mar; 10():19. PubMed ID: 20233412
[TBL] [Abstract][Full Text] [Related]
4. Cigarettes with different nicotine levels affect sensory perception and levels of biomarkers of exposure in adult smokers.
McKinney DL; Frost-Pineda K; Oldham MJ; Fisher MT; Wang J; Gogova M; Kobal G
Nicotine Tob Res; 2014 Jul; 16(7):948-60. PubMed ID: 24638852
[TBL] [Abstract][Full Text] [Related]
5. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
Shepperd CJ; Eldridge AC; Errington G; Dixon M
Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
[TBL] [Abstract][Full Text] [Related]
6. A comparison of urinary biomarkers of tobacco and carcinogen exposure in smokers.
Murphy SE; Link CA; Jensen J; Le C; Puumala SS; Hecht SS; Carmella SG; Losey L; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1617-23. PubMed ID: 15466978
[TBL] [Abstract][Full Text] [Related]
7. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is correlated with 8-hydroxy-2'-deoxyguanosine in humans after exposure to environmental tobacco smoke.
Chiang HC; Huang YK; Chen PF; Chang CC; Wang CJ; Lin P; Lee HL
Sci Total Environ; 2012 Jan; 414():134-9. PubMed ID: 22138374
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of Exposure and Biomarkers of Potential Harm in Adult Smokers Who Switch to e-Vapor Products Relative to Cigarette Smoking in a 24-week, Randomized, Clinical Trial.
Edmiston JS; Webb KM; Wang J; Oliveri D; Liang Q; Sarkar M
Nicotine Tob Res; 2022 Jun; 24(7):1047-1054. PubMed ID: 35134961
[TBL] [Abstract][Full Text] [Related]
9. A cross-sectional investigation of biomarkers of risk after a decade of smoking.
Calapai G; Caputi AP; Mannucci C; Gregg EO; Pieratti A; Aurora Russo G; Chaudhary N; Puntoni R; Lowe F; McEwan M; Bassi A; Morandi S; Nunziata A
Inhal Toxicol; 2009 Nov; 21(13):1138-43. PubMed ID: 19852556
[TBL] [Abstract][Full Text] [Related]
10. Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.
Melikian AA; Djordjevic MV; Chen S; Richie J; Stellman SD
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1408-15. PubMed ID: 17627005
[TBL] [Abstract][Full Text] [Related]
11. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers.
Liu J; Liang Q; Frost-Pineda K; Muhammad-Kah R; Rimmer L; Roethig H; Mendes P; Sarkar M
Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1760-9. PubMed ID: 21708936
[TBL] [Abstract][Full Text] [Related]
12. Relationships between cigarette consumption and biomarkers of tobacco toxin exposure.
Joseph AM; Hecht SS; Murphy SE; Carmella SG; Le CT; Zhang Y; Han S; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2963-8. PubMed ID: 16365017
[TBL] [Abstract][Full Text] [Related]
13. Binary classification of users of electronic cigarettes and smokeless tobacco through biomarkers to assess similarity with current and former smokers: machine learning applied to the population assessment of tobacco and health study.
Ohara H; Ito S; Takanami Y
BMC Public Health; 2023 Mar; 23(1):589. PubMed ID: 36991369
[TBL] [Abstract][Full Text] [Related]
14. Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.
Church TR; Anderson KE; Le C; Zhang Y; Kampa DM; Benoit AR; Yoder AR; Carmella SG; Hecht SS
Biomarkers; 2010 Jun; 15(4):345-52. PubMed ID: 20374068
[TBL] [Abstract][Full Text] [Related]
15. Toxicant exposure in cigarette reducers versus light smokers.
Hatsukami DK; Le CT; Zhang Y; Joseph AM; Mooney ME; Carmella SG; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2355-8. PubMed ID: 17164356
[TBL] [Abstract][Full Text] [Related]
16. Relationship of human toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol to levels of these biomarkers in plasma and urine.
Stepanov I; Hecht SS; Lindgren B; Jacob P; Wilson M; Benowitz NL
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1382-6. PubMed ID: 17627002
[TBL] [Abstract][Full Text] [Related]
17. Smokers of menthol and nonmenthol cigarettes exhibit similar levels of biomarkers of smoke exposure.
Heck JD
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):622-9. PubMed ID: 19190153
[TBL] [Abstract][Full Text] [Related]
18. Time to first cigarette and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels in adult smokers; National Health and Nutrition Examination Survey (NHANES), 2007-2010.
Branstetter SA; Muscat JE
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):615-22. PubMed ID: 23542804
[TBL] [Abstract][Full Text] [Related]
19. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers.
Prasad GL; Jones BA; Chen P; Gregg EO
Clin Chem Lab Med; 2016 Apr; 54(4):633-42. PubMed ID: 26495926
[TBL] [Abstract][Full Text] [Related]
20. Real-World Evidence of Differences in Biomarkers of Exposure to Select Harmful and Potentially Harmful Constituents and Biomarkers of Potential Harm Between Adult E-Vapor Users and Adult Cigarette Smokers.
Oliveri D; Liang Q; Sarkar M
Nicotine Tob Res; 2020 Jun; 22(7):1114-1122. PubMed ID: 31563966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]